<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04084899</url>
  </required_header>
  <id_info>
    <org_study_id>OSAS_bodypletysmo</org_study_id>
    <nct_id>NCT04084899</nct_id>
  </id_info>
  <brief_title>The Effect of CPAP on Lung Hyperinflation in Patients With OSA</brief_title>
  <official_title>The Effect of Continuous Positive Airway Pressure Therapy on Lung Hyperinflation in Patients With Obstructive Sleep Apnoea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Olomouc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Olomouc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of the lung hyperinflation by bodypletysmography in patients with obstructive
      sleep apnoea treated with continuous positive airway pressure therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale:

      Obstructive sleep apnoea (OSA) is characterized by repetitive closure of upper airways
      leading to apnoea (complete airflow cessation) or hypopnoea (airflow limitation &gt; 50% + blood
      oxygen desaturation &gt; 3% or airflow limitation &gt; 30% blood oxygen desaturation &gt; 4%). The
      prevalence of lung hyperinflations in sleep apnoea patients and effect of continuous positive
      airway pressure (CPAP) therapy is not known.

      Process:

      Subjects included in the study will be obstructive sleep apnoea (OSA) patients diagnosed by
      respiratory polysomnography performed in the Sleep Laboratory, Department of Respiratory
      Medicine, University Hospital Olomouc.

      Bodypletysmography will be performed in the time of OSA diagnosis and after 3 months of CPAP
      therapy.

      Data will be statistically evaluated after completion of the target number of subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 5, 2019</start_date>
  <completion_date type="Actual">January 9, 2020</completion_date>
  <primary_completion_date type="Actual">January 9, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Vital Capacity (VC) (ml)</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage change of Vital Capacity after 3 months of CPAP therapy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Forced Expiratory Volume in 1 second (FEV1) (ml)</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage change of Forced Expiratory Volume in 1 second after 3 months of CPAP therapy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Total Lung Capacity (TLC) (ml)</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage change of Total Lung Capacity after 3 months of CPAP therapy.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Residual Volume (RV) (ml)</measure>
    <time_frame>3 months</time_frame>
    <description>Percentage change of Residual Volume after 3 months of CPAP therapy.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>Continuous Positive Airway Pressure</arm_group_label>
    <description>Patient treated with continuous positive airway pressure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous Positive Airway Pressure therapy</intervention_name>
    <description>Standard treatment with continuous positive airway pressure</description>
    <arm_group_label>Continuous Positive Airway Pressure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with obstructive sleep apnoea syndrome indicated for CPAP therapy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Obstructive sleep apnoea syndrome indicated for CPAP therapy (Apnoea- Hypopnoea index
             ˃ 15)

        Exclusion Criteria:

          -  - Bilevel positive airway pressure therapy

          -  Total lung capacity &lt; 80% lower limit of normal values

          -  Obstructive ventilatory disorder

          -  Change in body weight ˃ 10%

          -  Change in smoking status
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milan Sova, MD, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Respiratory Medicine, University Hospital Olomouc</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>77900</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>September 5, 2019</study_first_submitted>
  <study_first_submitted_qc>September 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2019</study_first_posted>
  <last_update_submitted>January 9, 2020</last_update_submitted>
  <last_update_submitted_qc>January 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Olomouc</investigator_affiliation>
    <investigator_full_name>Milan Sova</investigator_full_name>
    <investigator_title>Principal Investigator, Head of Sleep Laboratory, Department of Respiratory Medicine</investigator_title>
  </responsible_party>
  <keyword>Obstructive Sleep Apnea</keyword>
  <keyword>Continuous Positive Airway Pressure</keyword>
  <keyword>Lung hyperinflation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

